跳至主要内容
临床试验/CTRI/2022/04/041608
CTRI/2022/04/041608已完成3 期

An open labelled randomised control clinical trial for the assessment of anxiolytic effect of Saraswat Ghrut and Satvavajay Chikitsa in management of Chittodvega w.s.r. Generalised Anxiety Disorder

DR APOORVA SANE0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18 – 60
  • 2. There will not be any economic barrier/ age barrier/ gender barrier.
  • 3. Patients with mild to moderate level of anxiety (below 14 points on GAD 7)
  • 4. Diabetes Mellitus & Hypertension

排除标准

  • 1. Uncontrolled Diabetes Mellitus, High BMI, Hyperlipidemic, any other Endocrinological disorders, etc.
  • 2. With severe cases post assessment of GAD 7 Scale (above 14)
  • 3. Pregnant & Lactating women
  • 4. With chronic contagious disease eg. TB or Hepatitis C

研究者

发起方
DR APOORVA SANE

相似试验